Darbepoetin and haemoglobin decreased Patient Reports February 11, 2012
Darbepoetin Side Effects Report #4664529-3
Darbepoetin side effect was reported by a Physician from on May 06, 2005. Male patient, weighting 165.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Darbepoetin. After drug was administered, patient experienced the following side effects: calculus ureteric, diarrhoea, haemoglobin decreased, hydronephrosis. Darbepoetin dosage: unknown. During the same period patient was treated with ALEVE. Patient was hospitalized. Patient recovered.
Darbepoetin Side Effects Report #4557250-3
Darbepoetin side effect was reported by a Consumer or non-health professional from on Mar 17, 2004. Male patient, weighting 160.1 lb, was diagnosed with dialysis
and was treated with Darbepoetin. After drug was administered, patient experienced the following side effects: arrhythmia
, arterial injury, coronary artery occlusion, coronary artery thrombosis, haemoglobin decreased. Darbepoetin dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, HECTORAL, VENOFER, VANCOMYCIN HYDROCHLORIDE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ASPIRIN, NEPHRO, BISACODYL. Patient died on 02/26/2004.Darbepoetin Side Effects Report #4664418-4
Darbepoetin side effect was reported by a Consumer or non-health professional from on Sept 24, 2002. Female patient, weighting 171.1 lb, was diagnosed with cardiac failure congestive and was treated with Darbepoetin. After drug was administered, patient experienced the following side effects: cerebral ischaemia, cerebrovascular accident, haemoglobin decreased. Darbepoetin dosage: unknown. During the same period patient was treated with DIGOXIN, LASIX, ATACAND, ASPIRIN, TOPROL, HYDRALAZINE, ZOCOR, GLUCOVANCE. Patient was hospitalized. Patient recovered.
Darbepoetin Side Effects Report #4896683-2
Darbepoetin side effect was reported by a Physician from UNITED STATES on Jan 18, 2006. Female patient, weighting 176.1 lb, was diagnosed with anaemia of malignant disease and was treated with Darbepoetin. After drug was administered, patient experienced the following side effects: bone marrow myelogram abnormal, haemoglobin decreased, metastatic neoplasm, pain in extremity, white blood cell count increased. Darbepoetin dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, TAXOTERE, INSULIN, ZETIA, NEULASTA, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.
Darbepoetin and haemoglobin decreased 